PREEMPTIVE PHARMACOGENETIC TESTING: EXPLORING THE KNOWLEDGE AND PERSPECTIVES OF UNITED STATES PAYERS

PURPOSE: Preemptive pharmacogenetic testing aims to optimize medication use by having genetic information at the point of prescribing. Payers’ decisions influence implementation of this technology. We investigated U.S. payers’ knowledge, awareness, and perspectives on preemptive pharmacogenetic test...

Descripción completa

Detalles Bibliográficos
Autores principales: Keeling, Nicholas J., Rosenthal, Meagen M., West-Strum, Donna, Patel, Amit, Haidar, Cyrine E., Hoffman, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920773/
https://www.ncbi.nlm.nih.gov/pubmed/31048813
http://dx.doi.org/10.1038/gim.2017.181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920773/
https://www.ncbi.nlm.nih.gov/pubmed/31048813
http://dx.doi.org/10.1038/gim.2017.181

Ejemplares similares